Bayer's leading oral contraceptives get US label update
This article was originally published in Scrip
Executive Summary
Bayer has updated the US label of its leading oral contraceptive pills, Yaz (3mg drospirenone/0.02mg ethinyl estradiol) and Yasmin (3mg drospirenone /0.03mg ethinyl estradiol), to include the results of four studies, including two which showed a comparable risk of thromboembolism with Yasmin compared with older contraceptives.